Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry.
A UijlJesse F VeenisH P Brunner-La RoccaV van EmpelG C M LinssenF W AsselbergsC van der LeeL W M EurlingsH KragtenN Y Y Al-WindyA van der SpankS KoudstaalJ J BrugtsA W HoesPublished in: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation (2021)
The medical HFpEF profile is determined by the underlying comorbidities, sex and age. Comorbidities are highly prevalent in HFpEF patients, especially in elderly HFpEF patients. Despite the lack of evidence, many HFpEF patients receive regular beta-blockers, RAS inhibitors and MRAs, often for the treatment of comorbidities.